These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2786561)

  • 41. Diagnosis of exocrine pancreatic insufficiency in cystic fibrosis by the synthetic peptide N-benzoyl-L-tyrosyl-p-aminobenzoic acid.
    Nousia-Arvanitakis S; Arvanitakis C; Desai N; Greenberger NJ
    J Pediatr; 1978 May; 92(5):734-7. PubMed ID: 305953
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Indirect parameters of pancreatic function in cystic fibrosis (CF) during a controlled double-blind trial of pancreatic supplementation.
    Regele S; Henker J; Münch R; Barbier Y; Stern M
    J Pediatr Gastroenterol Nutr; 1996 Jan; 22(1):68-72. PubMed ID: 8788290
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fecal alpha1-antitrypsin concentrations as a measure of enteric protein loss after modified fontan operations.
    Fujii T; Shimizu T; Takahashi K; Kishiro M; Ohkubo M; Akimoto K; Yamashiro Y
    J Pediatr Gastroenterol Nutr; 2003 Nov; 37(5):577-80. PubMed ID: 14581800
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alpha-1 antitrypsin and electrolytes in some cases of diarrhoea.
    el-Hawy AM; Abou-Taleb SA; Massoud AM; Abdel-Khalek YH
    J Egypt Soc Parasitol; 1989 Jun; 19(1):131-7. PubMed ID: 2785149
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A new faecal chymotrypsin method for evaluating the exocrine pancreatic function in patients with different pancreatic diseases.
    Lesi C; Melzi D'Eril GV; Scotta MS; Zoni L; Malaguti P
    Int J Pancreatol; 1988 Mar; 3(2-3):203-8. PubMed ID: 3361160
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Faecal chymotrypsin concentrations in neonates with cystic fibrosis and healthy controls.
    Brown GA; Halliday RB; Turner PJ; Smalley CA
    Arch Dis Child; 1988 Oct; 63(10):1229-33. PubMed ID: 3196049
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A single-specimen fecal chymotrypsin test in the diagnosis of pancreatic insufficiency: correlation with secretin-cholecystokinin and NBT-PABA tests.
    Lami F; Callegari C; Miglioli M; Barbara L
    Am J Gastroenterol; 1984 Sep; 79(9):697-700. PubMed ID: 6332529
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rapid semiquantitative tests for trypsin and chymotrypsin application to screening for cystic fibrosis, enterokinase deficiency and pancreatic hypoplasia in neonates.
    Robinson PG; Elliott RB
    N Z Med J; 1974 Jun; 79(517):1024-6. PubMed ID: 4527956
    [No Abstract]   [Full Text] [Related]  

  • 49. [Fecal chymotrypsin concentration in childhood. Normal values, specificity, sensitivity].
    Henker J; Hackbarth S; Sprössig C
    Helv Paediatr Acta; 1989 Jun; 43(5-6):397-404. PubMed ID: 2745136
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Qualitative study of fecal alpha-1-antitrypsin in patients with inflammatory digestive disease and patients with ileostomy].
    Colombel JF; Mizon C; Chekkouri N; Balduyck M; Chaussade S; Becuwe C; Degand P; Mizon J; Cortot A
    Gastroenterol Clin Biol; 1991; 15(4):301-5. PubMed ID: 2060740
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Carcinoembryonic antigen, alpha 1-antitrypsin, and alpha-fetoprotein in the pancreas of patients with cystic fibrosis.
    Scheele PM; Bendon RW; Ray MB
    Arch Pathol Lab Med; 1989 Oct; 113(10):1142-6. PubMed ID: 2478107
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Fecal excretion and the clearance of alpha 1-antitrypsin in patients with Crohn's disease].
    López A; Hinojosa J; Miralles A; Primo J; Bermúdez JD
    Rev Esp Enferm Dig; 1993 Apr; 83(4):235-9. PubMed ID: 8494651
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Fecal chymotrypsin in the evaluation of exocrine pancreatic function].
    Caiulo VA; Lupetti L; Cortigiani L; Ughi C; Ceccarelli M
    Pediatr Med Chir; 1989; 11(4):427-8. PubMed ID: 2616345
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Longitudinal follow-up of exocrine pancreatic function in pancreatic sufficient cystic fibrosis patients using the fecal elastase-1 test.
    Walkowiak J; Nousia-Arvanitakis S; Agguridaki C; Fotoulaki M; Strzykala K; Balassopoulou A; Witt M; Herzig KH
    J Pediatr Gastroenterol Nutr; 2003 Apr; 36(4):474-8. PubMed ID: 12658038
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structural heterogeneity of faecal alpha 1 antitrypsin shown by immunoblot analysis in patients with Crohn's disease.
    Boege F; Fischbach W
    Gut; 1991 May; 32(5):496-9. PubMed ID: 2040471
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Unresponsive or non-compliant steatorrhea in cystic fibrosis?
    Lisowska A; Kaminska B; Grzymislawski M; Herzig KH; Walkowiak J
    J Cyst Fibros; 2006 Dec; 5(4):253-5. PubMed ID: 16765107
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Decreased faecal exoglycosidase activities identify a subset of patients with active Crohn's disease.
    el Yamani J; Mizon C; Capon C; Colombel JF; Fournet B; Cortot A; Mizon J
    Clin Sci (Lond); 1992 Oct; 83(4):409-15. PubMed ID: 1330402
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sensitivity assessment of chymotrypsin faecal test in controlling malabsorption in cystic fibrosis.
    Santini B; Lerro P; Ciervo T; Robazza PV; Ansaldi N
    Acta Univ Carol Med (Praha); 1990; 36(1-4):165-8. PubMed ID: 2130685
    [No Abstract]   [Full Text] [Related]  

  • 59. Fecal alpha-1-antitrypsin concentration in patients with schistosomal hepatic fibrosis.
    el Aggan HA; Marzouk S
    J Egypt Soc Parasitol; 1992 Apr; 22(1):195-203. PubMed ID: 1578168
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Reduced activity of chymotrypsin in cystic fibrosis of the pancreas: enzyme deficiency or inactivated enzyme?].
    Neal JL; Girgis EA; Belmonte MM
    Union Med Can; 1973 Jul; 102(7):1465-70. PubMed ID: 4794652
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.